Amundi

SEC CIK: 0001330387
Latest filing: Aug 26, 2026

SEC filings (opens in a new tab)

ITCI holding history

Intra-Cellular Therapies, Inc. in every 13F filed by Amundi, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ITCI overview All 13F holders of ITCI Full Q2 2026 holdings

Shares (Q2 2025): 0; Sold out in Q2 2025
Value: $0
% of portfolio: 0.0%
Quarters held: 3; Since Q3 2024

Holdings of ITCI by Amundi, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2025	0	$0	0.0%	−561,266−100.0%	Sold out	Holders
Q1 2025	561,266	$74.0M	<0.1%	+558,537+20,466.7%	Added	Holders
Q4 2024	2,729	$225.3K	<0.1%	−206−7.0%	Reduced	Holders
Q3 2024	2,935	$212.5K	<0.1%	+2,935	New	Holders